Literature DB >> 34335310

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease.

Dongqing Wu1, Huaqing Zhu1, Hua Wang2,3.   

Abstract

As the largest vital solid organ in the body, liver is consisting of multiple types of cells including hepatocytes, Kupffer cell, hepatic stellate cells (HSCs), liver sinusoidal endothelial cells (LSECs), and other immune cells. The communication between these cells is critical in maintaining liver function homeostasis, and dysregulation of such communication contributes to the pathogenesis of various liver diseases. Extracellular vesicles (EVs), including exosomes and ectosomes, act as important mediators of cell-to-cell communication. EVs can be produced and uptaken by a wide range of cells including all types of cells in the liver. Growing evidences show that EVs are involved in the development of liver diseases, especially non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). In this review, we will summarize recent advance in how EVs production are altered in NAFLD and ALD and how the changes of EVs quantity and cargos influence the progression of these diseases. The therapeutic and diagnostic potential of EVs in NAFLD and ALD will be also discussed in this review.
Copyright © 2021 Wu, Zhu and Wang.

Entities:  

Keywords:  alcoholic liver disease; biomarker; extracellular vesicles; non-alcoholic fatty liver disease; pathogenesis

Year:  2021        PMID: 34335310      PMCID: PMC8316622          DOI: 10.3389/fphys.2021.707429

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  85 in total

Review 1.  Extracellular Vesicles: Unique Intercellular Delivery Vehicles.

Authors:  Sybren L N Maas; Xandra O Breakefield; Alissa M Weaver
Journal:  Trends Cell Biol       Date:  2016-12-13       Impact factor: 20.808

Review 2.  Extracellular vesicles: A bright star of nanomedicine.

Authors:  Peipei Wu; Bin Zhang; Dickson Kofi Wiredu Ocansey; Wenrong Xu; Hui Qian
Journal:  Biomaterials       Date:  2020-11-06       Impact factor: 12.479

3.  Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases.

Authors:  Shashi Bala; Jan Petrasek; Shiv Mundkur; Donna Catalano; Ivan Levin; Jeanine Ward; Hawau Alao; Karen Kodys; Gyongyi Szabo
Journal:  Hepatology       Date:  2012-07-26       Impact factor: 17.425

4.  Mitochondrial DNA-enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicity.

Authors:  Yan Cai; Ming-Jiang Xu; Erik H Koritzinsky; Zhou Zhou; Wei Wang; Haixia Cao; Peter St Yuen; Ruth A Ross; Robert A Star; Suthat Liangpunsakul; Bin Gao
Journal:  JCI Insight       Date:  2017-07-20

5.  MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages.

Authors:  Banishree Saha; Fatemeh Momen-Heravi; Karen Kodys; Gyongyi Szabo
Journal:  J Biol Chem       Date:  2015-11-02       Impact factor: 5.157

6.  Chronic-plus-binge alcohol intake induces production of proinflammatory mtDNA-enriched extracellular vesicles and steatohepatitis via ASK1/p38MAPKα-dependent mechanisms.

Authors:  Jing Ma; Haixia Cao; Robim M Rodrigues; Mingjiang Xu; Tianyi Ren; Yong He; Seonghwan Hwang; Dechun Feng; Ruixue Ren; Peixin Yang; Suthat Liangpunsakul; Jian Sun; Bin Gao
Journal:  JCI Insight       Date:  2020-07-23

Review 7.  Biological Nanotherapeutics for Liver Disease.

Authors:  Julia Driscoll; Cody Wehrkamp; Yu Ota; Jonathan N Thomas; Irene K Yan; Tushar Patel
Journal:  Hepatology       Date:  2021-08-30       Impact factor: 17.425

8.  Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS.

Authors:  Fatemeh Momen-Heravi; Shashi Bala; Karen Kodys; Gyongyi Szabo
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

9.  Alcohol-and-HIV-Induced Lysosomal Dysfunction Regulates Extracellular Vesicles Secretion in Vitro and in Liver-Humanized Mice.

Authors:  Raghubendra Singh Dagur; Moses New-Aaron; Murali Ganesan; Weimin Wang; Svetlana Romanova; Srivatsan Kidambi; Kusum K Kharbanda; Larisa Y Poluektova; Natalia A Osna
Journal:  Biology (Basel)       Date:  2021-01-05

Review 10.  Biogenesis, Membrane Trafficking, Functions, and Next Generation Nanotherapeutics Medicine of Extracellular Vesicles.

Authors:  Sangiliyandi Gurunathan; Min-Hee Kang; Muhammad Qasim; Khalid Khan; Jin-Hoi Kim
Journal:  Int J Nanomedicine       Date:  2021-05-18
View more
  5 in total

Review 1.  Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease.

Authors:  Chanbin Lee; Jinsol Han; Youngmi Jung
Journal:  Biology (Basel)       Date:  2022-04-21

2.  Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7.

Authors:  Rui Zuo; Li-Feng Ye; Yi Huang; Zi-Qing Song; Lei Wang; Hui Zhi; Min-Yi Zhang; Jie-Yi Li; Li Zhu; Wen-Jing Xiao; Hong-Cai Shang; Yang Zhang; Rong-Rong He; Yang Chen
Journal:  J Nanobiotechnology       Date:  2021-11-27       Impact factor: 10.435

3.  Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.

Authors:  Qingfu Zhu; Hengrui Li; Zheng Ao; Hao Xu; Jiaxin Luo; Connor Kaurich; Rui Yang; Pei-Wu Zhu; Sui-Dan Chen; Xiao-Dong Wang; Liang-Jie Tang; Gang Li; Ou-Yang Huang; Ming-Hua Zheng; Hui-Ping Li; Fei Liu
Journal:  J Nanobiotechnology       Date:  2022-07-27       Impact factor: 9.429

4.  Adipose-derived mesenchymal stem cell-secreted extracellular vesicles alleviate non-alcoholic fatty liver disease via delivering miR-223-3p.

Authors:  Qinghui Niu; Ting Wang; Zhiqiang Wang; Feng Wang; Deyu Huang; Huali Sun; Hanyun Liu
Journal:  Adipocyte       Date:  2022-12       Impact factor: 3.553

Review 5.  Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge.

Authors:  Longshan Ji; Qian Li; Yong He; Xin Zhang; Zhenhua Zhou; Yating Gao; Miao Fang; Zhuo Yu; Robim M Rodrigues; Yueqiu Gao; Man Li
Journal:  Acta Pharm Sin B       Date:  2022-05-11       Impact factor: 14.903

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.